{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:28:47Z","timestamp":1762298927652,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang University Research Foundation","award":["K17-518052-002"],"award-info":[{"award-number":["K17-518052-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5217-5","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T19:26:42Z","timestamp":1545852402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases"],"prefix":"10.1186","volume":"18","author":[{"given":"Juan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-7321","authenticated-orcid":false,"given":"Yongjie","family":"Shui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qichun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,27]]},"reference":[{"issue":"1","key":"5217_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1699-0463.1995.tb01074.x","volume":"103","author":"L Nedergaard","year":"1995","unstructured":"Nedergaard L, Haerslev T, Jacobsen GK. Immunohistochemical study of estrogen receptors in primary breast carcinomas and their lymph node metastases including comparison of two monoclonal antibodies. APMIS. 1995;103(1):20\u20134. \n                    https:\/\/doi.org\/10.1111\/j.1699-0463.1995.tb01074.x\n                    \n                  .","journal-title":"APMIS"},{"issue":"7","key":"5217_CR2","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1007\/s00268-010-0499-z","volume":"34","author":"AK Falck","year":"2010","unstructured":"Falck AK, Fern\u00f6 M, Bendahl PO, Ryd\u00e9n L. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer. World J Surg. 2010;34(7):1434\u201341. \n                    https:\/\/doi.org\/10.1007\/s00268-010-0499-z\n                    \n                  .","journal-title":"World J Surg"},{"issue":"6","key":"5217_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000345467","volume":"7","author":"B Ataseven","year":"2012","unstructured":"Ataseven B, Gologan D, Gunesch A, et al. HER2\/neu, topoisomerase 2a, estrogen and progesterone receptors: discordance between primary breast Cancer and metastatic axillary lymph node in expression and amplification characteristics. Breast Care (Basel). 2012;7(6):465\u201370. \n                    https:\/\/doi.org\/10.1159\/000345467\n                    \n                  .","journal-title":"Breast Care (Basel)"},{"issue":"3","key":"5217_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2217\/bmm.15.123","volume":"10","author":"A Adamczyk","year":"2016","unstructured":"Adamczyk A, Niemiec J, Ambicka A, et al. Survival of breast cancer patients according to changes in expression of selected markers between primary tumor and lymph node metastases. Biomark Med. 2016;10(3):219\u201328. \n                    https:\/\/doi.org\/10.2217\/bmm.15.123\n                    \n                  .","journal-title":"Biomark Med"},{"issue":"4","key":"5217_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.prp.2015.11.019","volume":"212","author":"MH Li","year":"2016","unstructured":"Li MH, Hou CL, Wang C, Sun AJ. HER-2, ER, PR status concordance in primary breast cancer and corresponding metastatic lesion in lymph node in Chinese women. Pathol Res Pract. 2016;212(4):252\u20137. \n                    https:\/\/doi.org\/10.1016\/j.prp.2015.11.019\n                    \n                  .","journal-title":"Pathol Res Pract"},{"issue":"8","key":"5217_CR6","first-page":"1597","volume":"57","author":"T Kuukasj\u00e4rvi","year":"1997","unstructured":"Kuukasj\u00e4rvi T, Karhu R, Tanner M, et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 1997;57(8):1597\u2013604.","journal-title":"Cancer Res"},{"issue":"10","key":"5217_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12032-014-0214-2","volume":"31","author":"YF Yang","year":"2014","unstructured":"Yang YF, Liao YY, Yang M, Peng NF, Xie SR, Xie YF. Discordances in ER, PR and HER2 receptors between primary and recurrent\/metastatic lesions and their impact on survival in breast cancer patients. Med Oncol. 2014;31(10):214. \n                    https:\/\/doi.org\/10.1007\/s12032-014-0214-2\n                    \n                  .","journal-title":"Med Oncol"},{"issue":"10","key":"5217_CR8","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.7314\/APJCP.2012.13.10.5047","volume":"13","author":"GN Sofi","year":"2012","unstructured":"Sofi GN, Sofi JN, Nadeem R, et al. Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Asian Pac J Cancer Prev. 2012;13(10):5047\u201352. \n                    https:\/\/doi.org\/10.7314\/APJCP.2012.13.10.5047\n                    \n                  .","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"5217_CR9","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/bcr2771","volume":"12","author":"AM Thompson","year":"2010","unstructured":"Thompson AM, Jordan LB, Quinlan P, et al. Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the breast recurrence in tissues study (BRITS). Breast Cancer Res. 2010;12(6):R92. \n                    https:\/\/doi.org\/10.1186\/bcr2771\n                    \n                  .","journal-title":"Breast Cancer Res"},{"issue":"3","key":"5217_CR10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10549-014-3136-y","volume":"147","author":"X Zhu","year":"2014","unstructured":"Zhu X, Ying J, Wang F, Wang J, Yang H. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China. Breast Cancer Res Treat. 2014;147(3):551\u20135. \n                    https:\/\/doi.org\/10.1007\/s10549-014-3136-y\n                    \n                  .","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"5217_CR11","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/annonc\/mdu053","volume":"25","author":"M Yi","year":"2014","unstructured":"Yi M, Huo L, Koenig KB, et al. Which threshold for ER positivity? A retrospective study based on 9639 patients. Ann Oncol. 2014;25(5):1004\u201311. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdu053\n                    \n                  .","journal-title":"Ann Oncol"},{"issue":"3","key":"5217_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10555-016-9631-3","volume":"35","author":"C Yeung","year":"2016","unstructured":"Yeung C, Hilton J, Clemons M, et al. Estrogen, progesterone, and HER2\/neu receptor discordance between primary and metastatic breast tumours-a review. Cancer Metastasis Rev. 2016;35(3):427\u201337. \n                    https:\/\/doi.org\/10.1007\/s10555-016-9631-3\n                    \n                  .","journal-title":"Cancer Metastasis Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5217-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T19:10:42Z","timestamp":1577387442000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5217-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5217"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5217-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"8 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted with the approval of the Shaoxing Hospital Institutional Review Board. Written informed consent was obtained from all participants. All study procedures were carried out in accordance with the ethical standards of the Helsinki Declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declared no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1290"}}